Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease

Virology
X J Da CostaDavid M Knipe

Abstract

A replication-defective mutant of herpes simplex virus 2 (HSV-2) was engineered by replacing the ICP8 gene of HSV-2 strain 186 with an ICP8-lacZ fusion gene from the herpes simplex virus 1 (HSV-1) HD-2 mutant strain. The resulting virus, HSV-2 5BlacZ, is defective for growth in Vero cells but is capable of growth in a cell line that expresses HSV-1 ICP8. In Vero cells, the mutant virus is defective for DNA synthesis but is able to express many viral proteins at levels similar to those of wild-type virus, including several of the late kinetic class. SDS-PAGE and Western blot analysis demonstrated the expression of glycoproteins B and D by 5BlacZ in Vero cells. Initial studies have shown that immunization with 5BlacZ protects guinea pigs from intravaginal HSV-2 challenge. Immunized animals had less severe genital skin disease and reduced replication of the challenge virus in the genital tract during primary infection and reduced episodes of recurrent disease. Thus, HSV-2 ICP8 shows gene regulatory properties similar to those of HSV-1 ICP8, and this HSV-2 ICP8 mutant virus shows a phenotype similar to those of HSV-1 ICP8 mutant strains. Replication-defective mutants of HSV-2 offer a potential vaccine approach for immune interventi...Continue Reading

References

Oct 1, 1976·Virology·J M Walboomers, J T Schegget
Nov 1, 1978·Journal of Virology·H S MarsdenN M Wilkie
Nov 1, 1991·Reviews of Infectious Diseases·L R Stanberry
Jul 1, 1988·The Journal of General Virology·D J McGeochP Taylor
Jan 1, 1985·Intervirology·L R StanberryJ C Overall
Jan 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P J Godowski, D M Knipe
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·M D Challberg
Apr 1, 1973·Virology·F L Graham, A J van der Eb
Sep 1, 1982·The Journal of Infectious Diseases·L R StanberryJ C Overall
Apr 1, 1996·The Journal of Infectious Diseases·N BourneD Lew
Mar 1, 1996·The Journal of Infectious Diseases·J D KrieselB A Araneo
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·R Leopardi, B Roizman

❮ Previous
Next ❯

Citations

Dec 17, 2009·Nature Structural & Molecular Biology·César SantiagoJosé M Casasnovas
Dec 5, 1998·AIDS Research and Human Retroviruses·J S Cairns, N Sarver
Jan 15, 2003·Clinical Microbiology Reviews·David M Koelle, Lawrence Corey
Apr 9, 1999·Sexually Transmitted Infections·L R Stanberry
Dec 3, 2011·The Journal of Clinical Investigation·Christine JohnstonAnna Wald
Jun 16, 2012·Future Virology·Xavier DervillezLbachir Benmohamed
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·X J Da CostaD M Knipe
Nov 7, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ayuko SatoAkiko Iwasaki
Jul 11, 2006·Folia Microbiologica·J Rajcáni, V Durmanová
Oct 14, 2005·Expert Review of Vaccines·David Bernstein
Mar 8, 2012·Reviews in Medical Virology·Erin Chung, Jonathan Sen
Feb 3, 2005·Seminars in Pediatric Infectious Diseases·Richard RuppLawrence R Stanberry
Jan 9, 2004·Expert Review of Vaccines·Cheryl A Jones, Anthony L Cunningham
Dec 17, 2014·Cell Reports·Zhong DengPaul M Lieberman
Dec 21, 2005·Virology·Tim Dudek, David M Knipe
Aug 15, 2002·British Medical Bulletin·M R WillsJ G P Sissons
Jan 9, 2010·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·César SantiagoJosé M Casasnovas
Mar 18, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L R StanberryC J Lacey
May 13, 2004·Clinical and Diagnostic Laboratory Immunology·L Aurelian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.